Gene: GPBP1L1
Official Full Name: GC-rich promoter binding protein 1 like 1provided by HGNC
Gene Summary: Predicted to enable DNA binding activity and RNA binding activity. Predicted to be involved in regulation of DNA-templated transcription. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17311 | GPBP1L1 Knockout cell line (HeLa) | Human | GPBP1L1 | 1:3~1:6 | Negative | Online Inquiry |
KO17312 | GPBP1L1 Knockout cell line (HCT 116) | Human | GPBP1L1 | 1:2~1:4 | Negative | Online Inquiry |
KO17313 | GPBP1L1 Knockout cell line (HEK293) | Human | GPBP1L1 | 1:3~1:6 | Negative | Online Inquiry |
KO17314 | GPBP1L1 Knockout cell line (A549) | Human | GPBP1L1 | 1:3~1:4 | Negative | Online Inquiry |
GPBP1L1 Gene Knockout Cell Lines are specialized cellular models that have been genetically modified to functionally delete the GPBP1L1 gene, an essential gene implicated in various cellular processes, including transcription regulation and cellular stress responses. By utilizing CRISPR-Cas9 gene-editing technology, these cell lines provide a powerful tool for exploring the biological role of GPBP1L1 in diverse tissues, as well as its associations with pathological conditions.
The primary mechanism behind GPBP1L1 Gene Knockout Cell Lines lies in the targeted disruption of the GPBP1L1 gene. This knockout results in the absence of the GPBP1L1 protein, allowing researchers to observe phenotypic changes, signaling pathways, and cellular behaviors that may occur in the absence of its function. Such insights can illuminate the gene's role in disease mechanisms and reveal potential therapeutic targets, especially in cancer and metabolic disorders.
In a research or clinical context, GPBP1L1 Gene Knockout Cell Lines are invaluable for functional genomics, drug discovery, and biomarker identification. They open avenues for studying gene-gene interactions and elucidating molecular mechanisms underpinning human diseases. Their significance extends to preclinical evaluative models that can accelerate the translation of findings from the bench to bedside.
Compared to alternative models, such as transient knockdown approaches or parental cell lines, the GPBP1L1 Gene Knockout Cell Lines provide a stable and reproducible platform for studies requiring long-term observations. Their gene specificity ensures that researchers can conduct experiments with high fidelity, reducing background noise that may arise from off-target effects.
For researchers, clinicians, and industry professionals, GPBP1L1 Gene Knockout Cell Lines represent a critical resource that couples cutting-edge genetic engineering with comprehensive biological insights. The direct application of this product enhances experimental rigor and can significantly influence therapeutic development strategies.
Our company specializes in delivering high-quality biological products tailored to meet the demands of modern scientific inquiry. With a commitment to excellence and innovation, we provide robust and reliable tools that empower researchers and clinicians to push the boundaries of knowledge and finding novel solutions to complex biological problems.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.